GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cereno Scientific AB (OSTO:CRNO B) » Definitions » Book Value per Share

Cereno Scientific AB (OSTO:CRNO B) Book Value per Share : kr0.59 (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Cereno Scientific AB Book Value per Share?

Cereno Scientific AB's book value per share for the quarter that ended in Mar. 2025 was kr0.59.

During the past 12 months, Cereno Scientific AB's average Book Value Per Share Growth Rate was -31.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -25.00% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -13.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Cereno Scientific AB was 186.40% per year. The lowest was -25.00% per year. And the median was -12.60% per year.

Cereno Scientific AB's current price is kr9.44. Its book value per share for the quarter that ended in Mar. 2025 was kr0.59. Hence, today's PB Ratio of Cereno Scientific AB is 15.92.

During the past 10 years, the highest P/B Ratio of Cereno Scientific AB was 16.10. The lowest was 0.00. And the median was 0.00.


Cereno Scientific AB Book Value per Share Historical Data

The historical data trend for Cereno Scientific AB's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cereno Scientific AB Book Value per Share Chart

Cereno Scientific AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.39 1.62 1.47 0.93 0.68

Cereno Scientific AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.86 0.90 0.82 0.68 0.59

Competitive Comparison of Cereno Scientific AB's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Cereno Scientific AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cereno Scientific AB's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cereno Scientific AB's PB Ratio distribution charts can be found below:

* The bar in red indicates where Cereno Scientific AB's PB Ratio falls into.


;
;

Cereno Scientific AB Book Value per Share Calculation

Cereno Scientific AB's Book Value Per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(191.93-0.00)/281.70
=0.68

Cereno Scientific AB's Book Value Per Share for the quarter that ended in Mar. 2025 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(167.01-0.00)/281.70
=0.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Cereno Scientific AB  (OSTO:CRNO B) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Cereno Scientific AB Book Value per Share Related Terms

Thank you for viewing the detailed overview of Cereno Scientific AB's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Cereno Scientific AB Business Description

Traded in Other Exchanges
Address
BioVentureHub, Pepparedsleden 1, Molndal, SWE, 431 83
Cereno Scientific AB is developing a pipeline of preventive therapeutics to treat cardiovascular and rare diseases by epigenetic modulation through histone deacetylase inhibition (HDACi). The company's lead program, CS1, is a phase two dual-acting antithrombotic drug aimed at venous thrombosis and stroke prevention for atrial fibrillation. Cereno Scientificalso evaluates the potential of epigenetic modulation for rare diseases related to pulmonary fibrosis, thrombosis, inflammation, and high blood pressure in the pulmonary circulation system.

Cereno Scientific AB Headlines

No Headlines